1. Home
  2. RENX vs NCNA Comparison

RENX vs NCNA Comparison

Compare RENX & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

HOLD

Current Price

$1.78

Market Cap

4.7M

Sector

N/A

ML Signal

HOLD

Logo NuCana plc

NCNA

NuCana plc

HOLD

Current Price

$1.34

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
NCNA
Founded
2021
1997
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.5M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
RENX
NCNA
Price
$1.78
$1.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
70.8K
61.2K
Earning Date
05-22-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,220,449.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3860.67
N/A
52 Week Low
$0.09
$1.21
52 Week High
$3.48
$7.01

Technical Indicators

Market Signals
Indicator
RENX
NCNA
Relative Strength Index (RSI) N/A 41.98
Support Level N/A $1.33
Resistance Level N/A $1.41
Average True Range (ATR) 0.00 0.09
MACD 0.00 -0.02
Stochastic Oscillator 0.00 3.45

Price Performance

Historical Comparison
RENX
NCNA

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

Share on Social Networks: